285 related articles for article (PubMed ID: 28935972)
1. Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder.
Hnoonual A; Thammachote W; Tim-Aroon T; Rojnueangnit K; Hansakunachai T; Sombuntham T; Roongpraiwan R; Worachotekamjorn J; Chuthapisith J; Fucharoen S; Wattanasirichaigoon D; Ruangdaraganon N; Limprasert P; Jinawath N
Sci Rep; 2017 Sep; 7(1):12096. PubMed ID: 28935972
[TBL] [Abstract][Full Text] [Related]
2. Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications.
Oikonomakis V; Kosma K; Mitrakos A; Sofocleous C; Pervanidou P; Syrmou A; Pampanos A; Psoni S; Fryssira H; Kanavakis E; Kitsiou-Tzeli S; Tzetis M
Clin Genet; 2016 Jun; 89(6):708-18. PubMed ID: 26777411
[TBL] [Abstract][Full Text] [Related]
3. MLPA is a practical and complementary alternative to CMA for diagnostic testing in patients with autism spectrum disorders and identifying new candidate CNVs associated with autism.
Capkova P; Srovnal J; Capkova Z; Staffova K; Becvarova V; Trkova M; Adamova K; Santava A; Curtisova V; Hajduch M; Prochazka M
PeerJ; 2019; 6():e6183. PubMed ID: 30647996
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficacy and new variants in isolated and complex autism spectrum disorder using molecular karyotyping.
Lovrečić L; Rajar P; Volk M; Bertok S; Gnidovec Stražišar B; Osredkar D; Jekovec Vrhovšek M; Peterlin B
J Appl Genet; 2018 May; 59(2):179-185. PubMed ID: 29564645
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
6. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
[TBL] [Abstract][Full Text] [Related]
8. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
Shin S; Yu N; Choi JR; Jeong S; Lee KA
Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analyses Support Previous and Novel Autism Candidate Genes: Outcomes of an Unexplored Brazilian Cohort.
da Silva Montenegro EM; Costa CS; Campos G; Scliar M; de Almeida TF; Zachi EC; Silva IMW; Chan AJS; Zarrei M; Lourenço NCV; Yamamoto GL; Scherer S; Passos-Bueno MR
Autism Res; 2020 Feb; 13(2):199-206. PubMed ID: 31696658
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.
Roberts JL; Hovanes K; Dasouki M; Manzardo AM; Butler MG
Gene; 2014 Feb; 535(1):70-8. PubMed ID: 24188901
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
12. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
[TBL] [Abstract][Full Text] [Related]
13. CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testing.
Innes J; Reali L; Clayton-Smith J; Hall G; Lim DH; Burghel GJ; French K; Khan U; Walker D; Lalloo F; Evans DGR; McMullan D; Maher ER; Woodward ER
J Med Genet; 2018 Feb; 55(2):89-96. PubMed ID: 28918392
[TBL] [Abstract][Full Text] [Related]
14. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
[TBL] [Abstract][Full Text] [Related]
15. Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders.
Akter H; Rahman MM; Sarker S; Basiruzzaman M; Islam MM; Rahaman MA; Rahaman MA; Eshaque TB; Dity NJ; Sarker S; Amin MR; Hossain MM; Lopa M; Jahan N; Hossain S; Islam A; Mondol A; Faruk MO; Saha N; Kundu GK; Kanta SI; Kazal RK; Fatema K; Rahman MA; Hasan M; Hossain Mollah MA; Hosen MI; Karuvantevida N; Begum G; Zehra B; Nassir N; Nabi AHMN; Uddin KMF; Uddin M
Front Genet; 2023; 14():955631. PubMed ID: 36959829
[No Abstract] [Full Text] [Related]
16. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
17. The landscape of copy number variations in Finnish families with autism spectrum disorders.
Kanduri C; Kantojärvi K; Salo PM; Vanhala R; Buck G; Blancher C; Lähdesmäki H; Järvelä I
Autism Res; 2016 Jan; 9(1):9-16. PubMed ID: 26052927
[TBL] [Abstract][Full Text] [Related]
18. Copy number variations in a Brazilian cohort with autism spectrum disorders highlight the contribution of cell adhesion genes.
Costa CIS; da Silva Montenegro EM; Zarrei M; de Sá Moreira E; Silva IMW; de Oliveira Scliar M; Wang JYT; Zachi EC; Branco EV; da Costa SS; Lourenço NCV; Vianna-Morgante AM; Rosenberg C; Krepischi ACV; Scherer SW; Passos-Bueno MR
Clin Genet; 2022 Jan; 101(1):134-141. PubMed ID: 34664255
[TBL] [Abstract][Full Text] [Related]
19. Can clinical characteristics be criteria to perform chromosomal microarray analysis in children and adolescents with autism spectrum disorders?
Sys M; van den Bogaert A; Roosens B; Lampo A; Jansen A; Wouters S; Keymolen K
Minerva Pediatr; 2018 Jun; 70(3):225-232. PubMed ID: 27607483
[TBL] [Abstract][Full Text] [Related]
20. Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.
Sheth F; Shah J; Jain D; Shah S; Patel H; Patel K; Solanki DI; Iyer AS; Menghani B; Mhatre P; Mehta S; Bajaj S; Patel V; Pandya M; Dhami D; Patel D; Sheth J; Sheth H
BMC Neurol; 2023 Aug; 23(1):292. PubMed ID: 37543562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
